Genentech Provides Update on Phase III Ocrevus High Dose Study in People With Relapsing Multiple Sclerosis
MUSETTE trial was designed to determine whether a higher dose of the currently approved Ocrevus IV 600 mg would provide…
Pediatric MS
Overview Pediatric-onset multiple sclerosis (POMS) occurs when MS is diagnosed before 18 years of age. Approximately 3%-5% of all individuals…
Stuart Schlossman
Current advances in the pharmacological prevention and management of cognitive dysfunction in multiple sclerosis
ABSTRACT Introduction Cognitive impairment (CI) is a core feature of Multiple Sclerosis (MS), being detectable in up to 65% of…
Stuart Schlossman
AAN 2025: Insights on Pediatric Multiple Sclerosis Treatment and Management
Author(s): Luke Halpern, Assistant Editor, Lauren B. Krupp, MD, FAAN Lauren B. Krupp, MD, FAAN, provides comprehensive guidance on treating…
Stuart Schlossman
AI tool effectively measures MS disease activity from 1 MRI scan
MindGlide to be used in research to assess brain damage, treatment by Marisa Wexler, MS | April 9, 2025 A…
Stuart Schlossman
A Short Guide to Disability Benefits for Veterans with MS
So, you have MS. You may also be a Veteran of the United States military. What kinds of benefits and…
Stuart Schlossman
Share Your Story: Military and Veterans Living with MS
Are you a veteran or active-duty service member? Your story helps us better understand the experiences of service members and…
Stuart Schlossman
Genentech Provides Update on Phase III Ocrevus High Dose Study in People With Relapsing Multiple Sclerosis
– MUSETTE trial was designed to determine whether a higher dose of the currently approved Ocrevus IV 600 mg would provide…
Stuart Schlossman
The Ultimate Travel Checklist for the Person with MS
You may want to plan ahead for traveling with multiple sclerosis (MS). This can include calling travel companies or airports,…
Stuart Schlossman
URGENT Message: MS Research Program (MSRP) Unfunded in Fiscal Year 2025 by Congress
Updated: March 18, 2025 On Tuesday, March 18, the National Multiple Sclerosis Society learned the Multiple Sclerosis Research Program (MSRP)…
Stuart Schlossman
